Clinical trials
Completed Leukemia, Myelomonocytic, Chronic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astex Pharmaceuticals, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Janssen Research & Development, LLC | 1 |
| Leukemia Research Fund | 1 |
| Prelude Therapeutics | 1 |
| Takeda | 1 |
| University of Leeds | 1 |
| Vion Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 13 |
| Leukemia, Myeloid, Acute | 11 |
| Myelodysplastic Syndromes | 11 |
| Leukemia | 4 |
| Congenital Abnormalities | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
| Lymphoma, T-Cell | 2 |
| Myelodysplastic-Myeloproliferative Diseases | 2 |
| Myeloproliferative Disorders | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.